BioDelivery Sciences Announces First Patient Enrollment in Phase 3 Clinical Study of Clonidine
April 03, 2014 at 07:13 AM EDT
BioDelivery Sciences International, Inc. (Nasdaq: BDSI) announced today the enrollment of the first patient in the RHAPSODY Study, a ...